Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26494710 |
US |
51 | 2 |
Pneumonia, Hypertension, Blood glucose increased, Product use in unapproved indication, |
||||
| 302 | 26495024 |
CN |
70 | 2 |
Insulin resistance, Drug ineffective, Weight increased, Blood glucose increased, Hyperglycaemia, |
||||
INSULIN DEGLUDEC, REPAGLINIDE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 303 | 26495241 |
74 | 2 | |
Blood glucose increased, |
||||
MAGNESIUM HYDROXIDE, |
||||
| 304 | 26495360 |
EU |
83 | 2 |
Syncope, Pollakiuria, Blood glucose increased, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, |
||||
| 305 | 26495565 |
US |
||
Dyspnoea exertional, Chills, Pruritus, Joint swelling, Blood pressure increased, Pain in jaw, Myalgia, Pain in extremity, Blood glucose increased, Arthralgia, Bone pain, Nausea, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, MACITENTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 306 | 26496026 |
US |
57 | 2 |
Blood glucose increased, Irritability, |
||||
TIRZEPATIDE, |
||||
| 307 | 26496376 |
US |
69 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 308 | 26496419 |
US |
1 | |
Mass, Blood glucose increased, |
||||
ORAL SEMAGLUTIDE, |
||||
| 309 | 26496465 |
US |
79 | 2 |
Syncope, Constipation, Rash, Blood glucose increased, |
||||
CAPIVASERTIB, MONTELUKAST, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, TORSEMIDE, FULVESTRANT, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, PROCHLORPERAZINE, NITROGLYCERIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EMPAGLIFLOZIN, |
||||
| 310 | 26496580 |
US |
63 | 1 |
Diabetic retinopathy, Blood glucose increased, Eye haemorrhage, Hypoacusis, Diabetic blindness, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 311 | 26496602 |
US |
63 | |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 312 | 26496658 |
US |
72 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, |
||||
| 313 | 26500337 |
74 | 2 | |
Blood glucose increased, Product prescribing issue, Needle issue, |
||||
INAVOLISIB, |
||||
| 314 | 26500404 |
80 | 2 | |
Blood glucose increased, Blood pressure increased, |
||||
EVOLOCUMAB, |
||||
| 315 | 26487643 |
IN |
2 | |
Pneumonia, Blood glucose increased, |
||||
INSULIN DEGLUDEC, |
||||
| 316 | 26488172 |
US |
1 | |
Blood glucose increased, Feeling abnormal, Insomnia, Injection site pain, Injection site bruising, |
||||
PREDNISONE, |
||||
| 317 | 26489244 |
US |
66 | 2 |
Blood glucose fluctuation, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 318 | 26489705 |
US |
71 | 2 |
Urinary tract infection, Atrial fibrillation, Blood glucose increased, Water intoxication, Blood sodium decreased, |
||||
CAPIVASERTIB, MAGNESIUM, ZOLPIDEM TARTRATE, FULVESTRANT, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DULAGLUTIDE, |
||||
| 319 | 26490058 |
US |
54 | 1 |
Ocular pemphigoid, Disease progression, Blood glucose increased, Hypertension, Anxiety, Illness, |
||||
PREDNISONE, INSULIN LISPRO, DAPAGLIFLOZIN, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 320 | 26490184 |
US |
2 | |
Liver disorder, Renal disorder, Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 321 | 26490296 |
IN |
||
Drug-induced liver injury, Metabolic acidosis, Peripheral sensorimotor neuropathy, Urine output decreased, Blood glucose increased, Myopathy, Rhabdomyolysis, |
||||
| 322 | 26490691 |
US |
72 | 2 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 323 | 26490957 |
GB |
43 | 2 |
Blood glucose increased, Blood creatinine increased, Sympathomimetic effect, Product use issue, |
||||
SEMAGLUTIDE, |
||||
| 324 | 26491015 |
US |
56 | 1 |
Blood glucose increased, White blood cell count decreased, |
||||
DAROLUTAMIDE, |
||||
| 325 | 26491160 |
EU |
70 | 2 |
Cataract, Fungal infection, Blood glucose increased, Fatigue, Thirst, Poor quality sleep, Hypertension, Hypercholesterolaemia, Fibromyalgia, Binge eating, Diarrhoea, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DAPAGLIFLOZIN, EMPAGLIFLOZIN, SITAGLIPTIN, LOSARTAN, BISOPROLOL FUMARATE, |
||||
| 326 | 26491645 |
75 | 1 | |
Anaphylactic shock, Blood pressure fluctuation, Tachypnoea, Oxygen saturation decreased, Heart rate increased, Dysphoria, Headache, Back pain, Pruritus, Hyperhidrosis, Erythema, PO2 decreased, Blood pH decreased, Blood sodium decreased, Blood potassium decreased, Blood lactic acid increased, Blood glucose increased, |
||||
IOPROMIDE, IOPROMIDE, IOPROMIDE, |
||||
| 327 | 26491878 |
US |
2 | |
Incorrect dose administered, Blood glucose increased, Expired product administered, |
||||
INSULIN LISPRO, TIRZEPATIDE, INSULIN GLARGINE, |
||||
| 328 | 26480585 |
US |
||
Blood glucose increased, |
||||
INAVOLISIB, |
||||
| 329 | 26481159 |
EG |
57 | 2 |
Blood glucose increased, Acute kidney injury, Blood urea increased, Hypotension, Ill-defined disorder, Diarrhoea, Vitamin D deficiency, Ischaemic stroke, Anal fistula, Tachycardia, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, BISOPROLOL FUMARATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ERGOCALCIFEROL, |
||||
| 330 | 26481608 |
US |
64 | 1 |
Blood glucose increased, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TIOTROPIUM BROMIDE, OLODATEROL RESPIMAT INHALATION SPRAY, ALLOPURINOL, |
||||
| 331 | 26481773 |
US |
||
Central hypothyroidism, Blood glucose increased, |
||||
OXCARBAZEPINE, |
||||
| 332 | 26483047 |
US |
74 | 1 |
Gout, Blood glucose increased, Cough, Peripheral swelling, |
||||
NIVOLUMAB, NIVOLUMAB, MIRTAZAPINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 333 | 26483518 |
US |
1 | |
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 334 | 26483588 |
US |
36 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 335 | 26483631 |
1 | ||
Blood glucose increased, Cerebrovascular accident, |
||||
SIROLIMUS, INSULIN GLARGINE, PREDNISONE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, FLUCONAZOLE, FUROSEMIDE, GLIPIZIDE, GLIPIZIDE-TABLETS, HYDRALAZINE HYDROCHLORIDE, SITAGLIPTIN, LEFLUNOMIDE, |
||||
| 336 | 26483663 |
US |
66 | |
Blood glucose increased, Urine odour abnormal, Blood glucose decreased, Drug hypersensitivity, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 337 | 26484019 |
US |
78 | 1 |
Blood glucose increased, Incorrect dose administered, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
| 338 | 26484298 |
US |
74 | 1 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 339 | 26484446 |
US |
69 | 1 |
Cellulitis, Blood glucose increased, Sepsis, |
||||
PEGLOTICASE, |
||||
| 340 | 26484628 |
68 | 2 | |
Blood glucose increased, Fluid retention, |
||||
| 341 | 26484693 |
US |
64 | |
Blood glucose increased, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, ORAL SEMAGLUTIDE, |
||||
| 342 | 26484789 |
BR |
56 | 2 |
Blood glucose increased, Incorrect dose administered by device, Device mechanical issue, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 343 | 26484843 |
US |
51 | 2 |
Blood glucose increased, Drug dose omission by device, Device failure, |
||||
INSULIN ASPART, |
||||
| 344 | 26484850 |
US |
52 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 345 | 26484854 |
US |
78 | 1 |
Pulmonary embolism, Pulmonary oedema, Hypophagia, Weight increased, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, FUROSEMIDE, |
||||
| 346 | 26484889 |
US |
77 | 1 |
Urinary tract infection, Delirium, Fall, Skin abrasion, Asthenia, Blood glucose increased, |
||||
EMPAGLIFLOZIN, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 347 | 26484937 |
US |
87 | 2 |
Macular degeneration, Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 348 | 26484983 |
BR |
1 | |
Mobility decreased, Fibromyalgia, Product blister packaging issue, Malaise, Treatment noncompliance, Tooth loss, Blood glucose increased, Inappropriate schedule of product administration, Dementia Alzheimer^s type, Prescription drug used without a prescription, Product packaging quantity issue, Drug ineffective for unapproved indication, Stress, Visual impairment, Parkinsonism, |
||||
DIVALPROEX SODIUM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, |
||||
| 349 | 26476133 |
US |
76 | 2 |
Neuropathy peripheral, Fatigue, Blood glucose increased, Globulins decreased, Vitamin B6 decreased, |
||||
ASFOTASE ALFA, |
||||
| 350 | 26476283 |
US |
53 | 2 |
Extra dose administered, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 351 | 26477429 |
US |
48 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 352 | 26477667 |
US |
75 | 1 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 353 | 26477737 |
US |
42 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 354 | 26477798 |
US |
75 | |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 355 | 26477841 |
65 | 1 | |
Blood glucose decreased, Blood glucose increased, Hyperphagia, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, |
||||
| 356 | 26477969 |
US |
1 | |
Drug resistance, Blood glucose increased, Drug ineffective, Blood glucose decreased, |
||||
INSULIN HUMAN, INSULIN LISPRO, INSULIN HUMAN, |
||||
| 357 | 26478259 |
CN |
62 | 2 |
Low density lipoprotein increased, Injection site bruising, Injection site discolouration, Blood glucose increased, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 358 | 26478271 |
US |
16 | 2 |
Sinus tachycardia, Aphasia, Abnormal behaviour, Depressed level of consciousness, Agitation, Dysarthria, Ataxia, Blood glucose increased, Muscle rigidity, Therapy interrupted, Overdose, |
||||
PERAMPANEL, PERAMPANEL, PERAMPANEL, |
||||
| 359 | 26478410 |
US |
||
Diarrhoea, Vomiting, Troponin increased, Therapy interrupted, Dyspnoea, Muscular weakness, Blood glucose increased, |
||||
VUTRISIRAN, |
||||
| 360 | 26478512 |
US |
76 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 361 | 26478823 |
1 | ||
Delirium, Blood glucose increased, Blood creatinine increased, Confusional state, |
||||
LENALIDOMIDE, |
||||
| 362 | 26479367 |
US |
68 | 2 |
Nephrolithiasis, Neuropathy peripheral, Balance disorder, Herpes zoster, Pain in extremity, Arthralgia, Blood glucose increased, Pain, Haemoglobin increased, COVID-19, Headache, Alopecia, Malaise, Nausea, |
||||
TIRZEPATIDE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, PREGABALIN, |
||||
| 363 | 26479775 |
US |
71 | 2 |
Blood glucose increased, Feeding disorder, Dehydration, Nausea, Vomiting, |
||||
PALBOCICLIB, FULVESTRANT, GLIMEPIRIDE, CANAGLIFLOZIN, INAVOLISIB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LORAZEPAM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, TIRZEPATIDE, MUPIROCIN, MUPIROCIN CALCIUM, AMLODIPINE BESYLATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, INSULIN GLARGINE, |
||||
| 364 | 26480276 |
JP |
64 | 2 |
Abdominal pain, Rash, Blood glucose increased, |
||||
CAPIVASERTIB, |
||||
| 365 | 26482370 |
75 | 1 | |
Anal incontinence, Blood glucose increased, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 366 | 26482892 |
62 | 1 | |
Acidosis, Blood glucose increased, Blood urea increased, Blood creatine increased, Glomerular filtration rate decreased, Blood potassium increased, Blood creatine phosphokinase increased, Troponin T increased, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 367 | 26471323 |
US |
78 | 2 |
Fatigue, Weight increased, Pruritus, Lethargy, Blood glucose increased, Blood cholesterol increased, |
||||
TOCILIZUMAB, |
||||
| 368 | 26471388 |
US |
58 | 1 |
Blood glucose increased, Muscle spasticity, Gait disturbance, Feeding disorder, Drug intolerance, Mouth haemorrhage, Alopecia, Incorrect dose administered, |
||||
RIPRETINIB, RIPRETINIB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, TIRZEPATIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, GLYBURIDE, |
||||
| 369 | 26471586 |
US |
75 | 1 |
Nephrolithiasis, Blood glucose increased, Glycosylated haemoglobin increased, Hypertonic bladder, Fatigue, Headache, Somnolence, Drug interaction, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LEVOKETOCONAZOLE, INSULIN HUMAN, |
||||
| 370 | 26471891 |
US |
||
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 371 | 26472039 |
US |
72 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 372 | 26472115 |
US |
82 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 373 | 26472461 |
73 | 2 | |
Blood glucose increased, Product dose omission issue, Off label use, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 374 | 26473497 |
US |
||
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 375 | 26473980 |
US |
52 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 376 | 26474212 |
CA |
33 | 2 |
Upper gastrointestinal haemorrhage, Diabetic ketoacidosis, Gastric ulcer, Sepsis, Nephrolithiasis, Product ineffective, Cortisol increased, Blood glucose increased, Stress, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 377 | 26474489 |
US |
81 | 2 |
Blood glucose increased, Glycosylated haemoglobin increased, |
||||
INCLISIRAN, |
||||
| 378 | 26474682 |
US |
62 | 1 |
Off label use, Blood glucose increased, Illness, Blood glucose decreased, |
||||
INSULIN HUMAN, |
||||
| 379 | 26474807 |
US |
61 | 1 |
Blood glucose increased, |
||||
EMPAGLIFLOZIN, ABEMACICLIB, |
||||
| 380 | 26474983 |
US |
23 | 2 |
Drug ineffective, Blood glucose increased, Intentional device misuse, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 381 | 26475338 |
US |
73 | 2 |
Abdominal adhesions, Hernia, Sepsis syndrome, Hallucination, Blood glucose increased, Gait inability, |
||||
INSULIN ASPART, |
||||
| 382 | 26475355 |
US |
57 | 1 |
Onychomycosis, Gangrene, Pain in extremity, Gait disturbance, Muscle tightness, Postoperative wound complication, Blood glucose increased, Fall, |
||||
INSULIN DEGLUDEC, |
||||
| 383 | 26475381 |
US |
2 | |
Joint injury, Neuropathy peripheral, Urinary tract infection, Fatigue, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 384 | 26475569 |
US |
63 | 2 |
Blood glucose increased, Sensation of blood flow, Swollen tongue, Hypertension, Asthenia, Tremor, Mass, Rash, Cataract, Blood glucose decreased, Vomiting, Dizziness, Cough, Injection site rash, Burning sensation, |
||||
INSULIN GLARGINE, INSULIN LISPRO, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 385 | 26475587 |
US |
61 | 1 |
Blood glucose increased, |
||||
EMPAGLIFLOZIN, ABEMACICLIB, |
||||
| 386 | 26475608 |
CN |
63 | 1 |
Blood pressure decreased, Blood glucose increased, Respiratory depression, Miosis, Coma, Toxicity to various agents, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 387 | 26470636 |
US |
49 | 1 |
Arthralgia, Pain in extremity, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 388 | 26470655 |
US |
77 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 389 | 26470693 |
US |
84 | 1 |
Urinary tract infection, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 390 | 26470710 |
US |
2 | |
Blood glucose increased, |
||||
EMPAGLIFLOZIN AND LINAGLIPTIN, GLIMEPIRIDE, |
||||
| 391 | 26470746 |
US |
66 | 2 |
Drug ineffective, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 392 | 26470761 |
US |
44 | 2 |
Product storage error, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 393 | 26470786 |
US |
80 | 2 |
Drug ineffective, Blood glucose increased, Hypoacusis, Visual impairment, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 394 | 26470815 |
US |
60 | 2 |
Blood glucose increased, Weight increased, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 395 | 26470922 |
US |
55 | 1 |
Increased appetite, Wrong technique in product usage process, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 396 | 26470999 |
US |
48 | 1 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 397 | 26471000 |
US |
65 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, |
||||
| 398 | 26471023 |
US |
68 | 1 |
Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 399 | 26471080 |
US |
65 | 1 |
Cellulitis, Sepsis, Skin infection, Skin injury, Neuropathy peripheral, Arrhythmia, Blood glucose increased, Irritability, |
||||
PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, |
||||
| 400 | 26471127 |
US |
2 | |
Blood pressure increased, Blood glucose increased, Weight increased, |
||||
EVOLOCUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28